TNYA (STOCKS)
Tenaya Therapeutics, Inc. Common Stock
$0.742900
-0.020600 (-2.70%)
Prev close: $0.763500
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Faraz Ali
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $172.37M
- Employees
- 97
- P/E (TTM)
- -1.39
- P/B (TTM)
- 2.47
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.20 | $-0.07 | -0.1303 | -186.94% |
|
Mar 2026 (Q1)
|
$-0.09 | $-0.09 | -0.0011 | -1.24% |
|
Dec 2025 (Q4)
|
$-0.12 | $-0.12 | +0.0037 | +2.99% |
|
Sep 2025 (Q3)
|
$-0.12 | $-0.15 | +0.0307 | +20.37% |
Financial Statements
| Revenues | $1.34M |
| Nonoperating Income/Loss | $2.75M |
| Operating Expenses | $107.20M |
| Depreciation and Amortization | $7.20M |
| Research and Development | $61.61M |
| Other Operating Expenses | $38.39M |
| Operating Income/Loss | -$105.87M |
| Income/Loss From Continuing Operations After Tax | -$103.12M |
| Income/Loss From Continuing Operations Before Tax | -$103.12M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$103.12M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$103.12M |
| Net Income/Loss Available To Common Stockholders, Basic | -$103.12M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.52 |
| Diluted Earnings Per Share | -$0.52 |
| Basic Average Shares | 388,016,547 |
| Diluted Average Shares | 388,016,547 |
| Assets | $93.54M |
| Current Assets | $86.01M |
| Cash | $78.10M |
| Prepaid Expenses | $3.49M |
| Other Current Assets | $4.42M |
| Noncurrent Assets | $7.53M |
| Fixed Assets | $2.49M |
| Other Non-current Assets | $5.04M |
| Liabilities | $24.13M |
| Current Liabilities | $19.02M |
| Accounts Payable | $2.90M |
| Other Current Liabilities | $16.12M |
| Noncurrent Liabilities | $5.11M |
| Equity | $69.41M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $69.41M |
| Liabilities And Equity | $93.54M |
| Net Cash Flow From Operating Activities | -$52.33M |
| Net Cash Flow From Operating Activities, Continuing | -$52.33M |
| Net Cash Flow From Investing Activities | $8.62M |
| Net Cash Flow From Investing Activities, Continuing | $8.62M |
| Net Cash Flow From Financing Activities | $59.12M |
| Net Cash Flow From Financing Activities, Continuing | $59.12M |
| Net Cash Flow | $15.41M |
| Net Cash Flow, Continuing | $15.41M |
| Comprehensive Income/Loss | -$103.11M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$103.11M |
| Other Comprehensive Income/Loss | $1.00K |